IndexIQ Advisors’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,245
Closed -$140K 1573
2021
Q4
$140K Sell
20,245
-1,308
-6% -$19.2K ﹤0.01% 1057
2021
Q3
$267K Buy
21,553
+2,159
+11% +$31.1K 0.01% 1007
2021
Q2
$354K Sell
19,394
-515
-3% -$10.2K 0.01% 893
2021
Q1
$415K Buy
19,909
+3,798
+24% +$80K 0.01% 481
2020
Q4
$288K Buy
16,111
+1,663
+12% +$25K 0.01% 705
2020
Q3
$164K Buy
14,448
+784
+6% +$9.69K 0.01% 797
2020
Q2
$186K Sell
13,664
-606
-4% -$8.35K 0.01% 664
2020
Q1
$186K Buy
+14,270
New +$254K 0.01% 555

Other funds holding RDUS

IndexIQ Advisors's RDUS Position: Q1 2022 in Review

IndexIQ Advisors sold out of Radius Health, Inc. (RDUS) in Q1 2022, closing a stake of 20,245 shares — an estimated $140K sold.

IndexIQ Advisors first reported a position in RDUS in Q1 2020 and held it in 8 quarters. The position peaked at $415K in Q1 2021. 138 funds tracked by Wall St. Rank hold RDUS as of Q1 2022.

  • IndexIQ Advisors reported no remaining Radius Health, Inc. position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 20,245 Radius Health, Inc. shares in Q1 2022, an estimated $140K.
  • IndexIQ Advisors first reported a position in Radius Health, Inc. in Q1 2020 and held it in 8 quarters.
  • IndexIQ Advisors's Radius Health, Inc. position peaked at $415K in Q1 2021.
  • 138 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.